Edition:
United States

People: Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

29.91USD
28 Apr 2017
Change (% chg)

$-0.40 (-1.32%)
Prev Close
$30.31
Open
$30.36
Day's High
$30.38
Day's Low
$29.82
Volume
513,645
Avg. Vol
373,114
52-wk High
$44.38
52-wk Low
$24.47

Havey, Adam 

Mr. Adam Havey is Executive Vice President - Business Operations of the Company. He previously served as our executive vice president and president, biodefense division from March 2011 to March 2017; president of Emergent Biodefense Operations Lansing LLC from January 2010 to February 2011; vice president of business operations from November 2007 to December 2008; and senior director of manufacturing development from June 2006 to November 2007. Mr. Havey received a B.S. in chemical engineering from Michigan State University.

Basic Compensation

Total Annual Compensation, USD 431,019
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 557,050
Fiscal Year Total, USD 988,069

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 11,427 1,154,510.00
Name Fiscal Year Total

Fuad El-Hibri

2,428,930

Daniel Abdun-Nabi

3,185,070

Robert Kramer

1,475,060

Adam Havey

988,069

Ronald Richard

382,493

Sue Bailey

331,993
As Of  30 Dec 2016